Beyls Christophe, Martin Nicolas, Booz Thomas, Viart Christophe, Boisgard Solenne, Daumin Camille, Crombet Maxime, Epailly Julien, Huette Pierre, Dupont Hervé, Abou-Arab Osama, Mahjoub Yazine
Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France.
UR UPJV 7518 SSPC (Simplification of Care of Complex Surgical Patients) Research Unit, Jules Verne University of Picardie, Amiens, France.
Front Med (Lausanne). 2022 Oct 4;9:824994. doi: 10.3389/fmed.2022.824994. eCollection 2022.
It is known that acute cor pulmonale (ACP) worsens the prognosis of non-coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (NC-ARDS). The ACP risk score evaluates the risk of ACP occurrence in mechanically ventilated patients with NC-ARDS. There is less data on the risk factors and prognosis of ACP induced by COVID-19-related pneumonia.
The objective of this study was to evaluate the prognostic value of ACP, assessed by transthoracic echocardiography (TTE) and clinical factors associated with ACP in a cohort of patients with COVID-19-related pneumonia.
Between February 2020 and June 2021, patients admitted to intensive care unit (ICU) at Amiens University Hospital for COVID-19-related pneumonia were assessed by TTE within 48 h of admission. ACP was defined as a right ventricle/left ventricle area ratio of >0.6 associated with septal dyskinesia. The primary outcome was mortality at 30 days.
Among 146 patients included, 36% ( = 52/156) developed ACP of which 38% ( = 20/52) were non-intubated patients. The classical risk factors of ACP (found in NC-ARDS) such as PaCO >48 mmHg, driving pressure >18 mmHg, and PaO/FiO < 150 mmHg were not associated with ACP (all -values > 0.1). The primary outcome occurred in 32 (22%) patients. More patients died in the ACP group ( = 20/52 (38%) vs. = 12/94 (13%), = 0.001). ACP [hazards ratio (HR) = 3.35, 95%CI [1.56-7.18], = 0.002] and age >65 years (HR = 2.92, 95%CI [1.50-5.66], = 0.002) were independent risk factors of 30-day mortality.
ACP was a frequent complication in ICU patients admitted for COVID-19-related pneumonia. The 30-day-mortality was 38% in these patients. In COVID-19-related pneumonia, the classical risk factors of ACP did not seem relevant. These results need confirmation in further studies.
已知急性肺心病(ACP)会使非2019冠状病毒病(COVID-19)急性呼吸窘迫综合征(NC-ARDS)的预后恶化。ACP风险评分评估机械通气的NC-ARDS患者发生ACP的风险。关于COVID-19相关肺炎所致ACP的危险因素和预后的数据较少。
本研究的目的是评估经胸超声心动图(TTE)评估的ACP的预后价值以及COVID-19相关肺炎患者队列中与ACP相关的临床因素。
在2020年2月至2021年6月期间,对入住亚眠大学医院重症监护病房(ICU)的COVID-19相关肺炎患者在入院后48小时内进行TTE评估。ACP定义为右心室/左心室面积比>0.6且伴有室间隔运动障碍。主要结局是30天死亡率。
在纳入的146例患者中,36%(=52/156)发生了ACP,其中38%(=20/52)为非插管患者。ACP的经典危险因素(在NC-ARDS中发现),如动脉血二氧化碳分压(PaCO)>48 mmHg、驱动压>18 mmHg和动脉血氧分压/吸入氧分数值(PaO/FiO)<150 mmHg与ACP无关(所有P值>0.1)。32例(22%)患者出现主要结局。ACP组死亡患者更多(=20/52(38%)对=12/94(13%),P=0.001)。ACP[风险比(HR)=3.35,95%置信区间[1.56 - 7.18],P=0.002]和年龄>65岁(HR = 2.92,95%置信区间[1.50 - 5.66],P=0.002)是30天死亡率的独立危险因素。
ACP是入住ICU的COVID-19相关肺炎患者的常见并发症。这些患者的30天死亡率为38%。在COVID-19相关肺炎中,ACP的经典危险因素似乎不相关。这些结果需要在进一步研究中得到证实。